32800sek
1,7 %
Date:2026-07-09Time:18:00:00Latest report:Q1-2026List:Large CapTicker:BIOA B
Market Cap:29 101 msekEnterprise Value:27 108 msekNet Sales:1 147 msekEarnings:213,2 msekEmployees:0ISIN:SE0010323311

Ratios

10-year key figure history for BioArctic turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BioArctic with index and moving average MA50 and MA200.

Stockprice:328,00
MA50:317,86
MA200:311,51
Price/MA200:5,3 %
RSI (14):58,2
Price/MA50:3,2 %

Description

BioArctic is a biopharmaceutical company focused on developing new treatments that address the causes of neurodegenerative diseases. Examples of diseases include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. BioArctic was founded in 2003 and is headquartered in Stockholm.

Biotechnology